The demand for OTC glucose monitors in USA is projected to grow from USD 587.2 million in 2025 to USD 1,299.1 million by 2035, at a CAGR of 8.3%. Continuous glucose monitors will dominate with a 55.4% market share, while diabetes type i will lead the indication segment with a 66.3% share.